Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03391778 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT03391778 · ClinicalTrials.gov record · last posted 2026-08-11

Adoptive Cell Therapy Long-term Follow-up (LTFU) Study

Name: Adoptive Cell Therapy Long-term Follow-up (LTFU) Study — clinical trial record (NCT03391778)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusEnrolling by Invitation

PhasePhase 1

SponsorUSWM CT, LLC

Started2018-04-09

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

This trial will evaluate long term safety of participants who have received AdaptImmune (ADP) adoptive cell therapy for up to 15 years following last adoptive cell therapy infusion.

Protocol amendment history 1 change detected by DataLookout

2026-08-12

Trial status changed: Recruiting → Enrolling by Invitation

Trial Details

NCT Number	NCT03391778
Lead Sponsor	USWM CT, LLC
Conditions	Neoplasms
Enrollment	250 participants
Start Date	2018-04-09
Primary Completion	2032-04-01 (estimated)
Study Completion	2032-04-01 (estimated)
Updated on ClinicalTrials.gov	2026-08-11